Top Markets
#1 ONFA ONFA +229.27%
#2 Resolv wstUSR Resolv wstUSR +198.03%
#3 NKN NKN +45.12%
#4 Noon Noon +41.33%
#5 Doge Strategy Doge Strategy +38.28%
#6 Liquid Mercury Liquid Mercury +32.29%
#7 DeAgentAI DeAgentAI +31.48%
#8 StakeStone StakeStone +28.35%
#9 BLOCKv BLOCKv +25.34%
#10 KONET KONET +19.76%
Coin of the day
ONFA ONFA
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Becton, Dickinson and Company Becton, Dickinson and Company

Becton, Dickinson and Company

BDX
Classifica tra le azioni #389
Becton, Dickinson and Company develops, manufactures, and sells medical... Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Prezzo delle azioni
$154.51
Capitalizzazione di mercato
$55.98B
Variazione (1 giorno)
-1.82%
Variazione (1 anno)
-32.08%
Paese
US
Scambia Becton, Dickinson and Company (BDX)

Categoria

Healthcare
Rapporto P/B per Becton, Dickinson and Company (BDX)
Rapporto P/B al March 2026 TTM: 1.80
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Becton, Dickinson and Company, il rapporto P/B attuale (TTM) è 1.80. Alla fine del 2024, era pari a 2.70.
Storico del rapporto P/B per Becton, Dickinson and Company da 2000 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
2026 (TTM) 1.80 -14.84%
2025 2.11 -21.70%
2024 2.70 -5.94%
2023 2.87 14.21%
2022 2.51 -14.21%
2021 2.93 9.96%
2020 2.66 -15.67%
2019 3.16 -0.44%
2018 3.17 -1.81%
2017 3.23 -33.83%
2016 4.88 33.54%
2015 3.66 -13.87%
2014 4.24 12.47%
2013 3.77 -1.29%
2012 3.82 16.77%
2011 3.27 5.12%
2010 3.11 -2.04%
2009 3.18 -17.91%
2008 3.87 -14.60%
2007 4.54 2.05%
2006 4.44 13.51%
2005 3.92 -5.24%
2004 4.13 33.56%
2003 3.09 7.71%
2002 2.87 -27.37%
2001 3.95 18.53%
2000 3.34 0.00%
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Intuitive Surgical, Inc. Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
ISRG.US
 9.4013 423.20%
US
Sartorius Aktiengesellschaft Sartorius Aktiengesellschaft
Sartorius Aktiengesellschaft
SOAGY.US
 5.3496 197.71%
DE
HOYA Corporation HOYA Corporation
HOYA Corporation
HOCPY.US
 9.1505 409.24%
JP
Alcon Inc. Alcon Inc.
Alcon Inc.
ALC.US
 1.717 -4.45%
CH
ResMed Inc. ResMed Inc.
ResMed Inc.
RMD.US
 5.3492 197.69%
US